Strong growth momentum and solid performance Athens, Greece – October 23, 2024 – GR. Sarantis S.A. (SAR.AT, SAR:GA) announces its nine-month trading update for the period ended September 30th, 2024. Nine-month 2024 highlights Strong 9m Net Sales performance driven by focused execution of our strategic priorities 9m 2024 Reported Net Sales (including Stella Pack) grew to €452.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 22nd 2024 with the purchase of 2,000 own shares at the average price of 10.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 18th 2024 with the purchase of 2,000 own shares at the average price of 11.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 17th 2024 with the purchase of 3,000 own shares at the average price of 11.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 16th 2024 with the purchase of 4,175 own shares at the average price of 11.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 15th 2024 with the purchase of 6,669 own shares at the average price of 10.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on October 14th 2024 with the purchase of 9,100 own shares at the average price of 10.
Sarantis Group has once again confirmed its strong presence in the pharmaceutical market by winning nine significant awards at the Best in Pharmacy Awards 2024. Organized for the 7th consecutive year in Greece by BOUSSIAS Events, these awards recognize outstanding performance in pharmacy products, creativity, and strategic marketing practices that promote these products in the market.
Want to learn more about the Group?
Explore our latest news regarding our brands, our activities, our people and our sustainability actions!
SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com